Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | 0.0% | 0.0% | 0.0% | 1,372.3% | 971.7% | 2,030.0% | 1,653.2% | (35,015.4%) | (13,440.4%) | 4,169.5% | 1,429.3% | 5,037.7% | (48.6%) | (2,255.5%) | (50,419.7%) | (1,018.4%) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is (400.0%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Aadi Bioscience, Inc. have been (1,260.4%) over the past three years, and 245.5% over the past five years.
As of today, Aadi Bioscience, Inc.'s ROIC - WACC is (400.0%), which is lower than industry median of (132.6%). It indicates that Aadi Bioscience, Inc.'s ROIC - WACC is Bad.